Medicare Enrolled
Dr. Robert Husney, MD
Infectious Disease · Brooklyn, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Husney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Husney?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Husney
Dr. Robert Husney is an infectious disease specialist in Brooklyn, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Husney performed 10,893 Medicare services across 3,350 unique beneficiaries.
Between the years covered by Open Payments, Dr. Husney received a total of $4,644 from 25 pharmaceutical and/or device companies across 234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Husney is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in NY
$4,644 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,893
Medicare services
Top 1% in NY for infectious disease
3,350
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~605 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
4,716 | $74 | $141 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
2,983 | $69 | $200 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
751 | $122 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
511 | $111 | $400 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
490 | $122 | $300 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
286 | $70 | $120 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
250 | $79 | $200 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 201 | $74 | $230 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
118 | $162 | $307 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
111 | $35 | $150 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
105 | $201 | $387 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
70 | $43 | $125 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
49 | $115 | $275 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
44 | $53 | $150 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
42 | $169 | $350 |
| Hepatitis B vaccine administration This procedure involves the injection of the hepatitis B vaccine to provide immunization against the hepatitis B virus. |
33 | $34 | $35 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
23 | $241 | $300 |
| Hepatitis B vaccine, adult dosage An injection of the hepatitis B vaccine administered to adults as part of a three-dose immunization schedule. |
19 | $69 | $125 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
19 | $34 | $35 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 18 | $20 | $70 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $99 | $350 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
14 | $5 | $40 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
13 | $152 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $159 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,644
Total received (2018-2024)
Avg $663/year across 7 years
Top 18% in NY for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
234
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,644 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$779
2023
$994
2022
$853
2021
$661
2020
$446
2019
$331
2018
$580
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ViiV Healthcare Company
$343
Gilead Sciences, Inc.
$135
Lilly USA, LLC
$64
GlaxoSmithKline, LLC.
$64
Renalytix AI, Inc.
$55
E.R. Squibb & Sons, L.L.C.
$37
Insmed, Inc.
$22
PFIZER INC.
$20
AstraZeneca Pharmaceuticals LP
$20
Esperion Therapeutics, Inc.
$18
Top 3 companies account for 69.7% of 2024 payments
All-time payments by company (2018-2024) ›
ViiV Healthcare Company
$1,579
Gilead Sciences, Inc.
$821
Lilly USA, LLC
$477
GlaxoSmithKline, LLC.
$409
E.R. Squibb & Sons, L.L.C.
$216
Amgen Inc.
$162
Merck Sharp & Dohme Corporation
$154
Global Blood Therapeutics, Inc.
$110
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$106
Merck Sharp & Dohme LLC
$89
PFIZER INC.
$83
AbbVie Inc.
$67
Renalytix AI, Inc.
$55
VBI Vaccines (Delaware) Inc.
$48
Circassia Pharmaceuticals Inc
$47
Janssen Biotech, Inc.
$39
Genentech USA, Inc.
$24
IRONWOOD PHARMACEUTICALS, INC
$23
Novartis Pharmaceuticals Corporation
$23
Insmed, Inc.
$22
Melinta Therapeutics, Inc.
$20
AstraZeneca Pharmaceuticals LP
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Esperion Therapeutics, Inc.
$18
Shire North American Group Inc
$15
Top 3 companies account for 61.9% of all-time payments
Associated products mentioned in payments ›
ANORO · APRETUDE · AREXVY · Aimovig · Arikayce · BREO · CABENUVA · CAMZYOS · CHANTIX · DOVATO · ELIQUIS · ENTRESTO · FARXIGA · JANUVIA · JARDIANCE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · LINZESS · Linzess · MOUNJARO · NEXLETOL · OXBRYTA · PAXLOVID · PIFELTRO · PREZCOBIX · PreHevbrio · Prolia · Repatha · SHINGRIX · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · UBRELVY · Vabomere · XIFAXAN · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Infectious diseases within 10 mi
652
Per 100K population
24.6
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Husney is a mixed practice specialist, with above-average Medicare volume (top 1% in NY), with low-engagement industry engagement in the top 18% of NY peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Husney experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Husney performed 4,716 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Husney receive payments from pharmaceutical companies?
Yes. Dr. Husney received a total of $4,644 from 25 companies across 234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Husney's costs compare to other infectious diseases in Brooklyn?
Dr. Husney's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Husney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in Brooklyn
Browse infectious diseases in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in NY
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in NY
Which NY infectious diseases receive the most from drug and device companies.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology